A1RG34:BVMF
Argenx Se Bdr
R$ २२२.१७
०.००%
(०.००) 1D
नोभेम्बर १२, १५:०२:५३ GMT-३ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Mkt. cap
६०.४९ अरब
Avg. vol.
४७.००
Volume
०.००
52-wk high
R$ २१६.००
52-wk low
R$ १४३.२२
Shares outstanding
६.२९ करोड
No. of employees
२ हजार
Mkt. cap
६०.४९ अरब
Avg. vol.
४७.००
Volume
०.००
52-wk high
R$ २१६.००
52-wk low
R$ १४३.२२
Shares outstanding
६.२९ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
TradingKey
·
५ घण्टा पहिले
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
Foreign Policy Journal
·
२ घण्टा पहिले
Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade
TradingView
·
१० घण्टा पहिले
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
Traders Union
·
१० घण्टा पहिले
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr